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The expression of the SmB and SmB' spliceosome proteins in a variety of cell types and tissues has been investigated. 
Although SmB is found in all cells studied, the StuB' protein is found only in a small number of rodent cell types. The 
presence of this protein is correlated with the ability to utilize an alternative pathway of RNA splicing which is not availa- 
ble in most cell types. This is the first demonsIration f tissue specific expression of a protein component of the spliceo- 
some and suggests a role for SmB' in the regulation of some cases of alternative RNA splicing. 
RNA splicing alternative; Autoimmuno antigen; Tissue-specific expression 
1. INTRODUCTION 
Numerous examples of alternative RNA pro- 
cessing, producing different mRNAs from the 
same primary transcript in different cell types have 
been reported [1-4]. In contrast, the components 
of the splicing apparatus such as the Sm proteins 
and SnRNAs appear to be expressed in all tissues 
[5-7] paralleling the widespread requirement for 
processing of the primary transcript [8]. 
To investigate whether differences in these com- 
ponents occur between different tissues which 
might play a role in alternative splicing, we have 
studied the expression of two Sm proteins, B and 
B' [9]. These two proteins are closely related, the 
slightly larger StuB' protein (29 kDa compared to 
28 kDa) containing an additional peptide not 
found in StuB. Both proteins are readily detectable 
in human cells [10,11], although studies on their 
expression in rat liver [12] and Friend cells [10] 
failed to detect StuB' in these rodent cell types. 
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Here we report that whilst SmB is detectable in
all cells, SmB' is only detectable ina small number 
of rodent cell types. The presence of StuB' in these 
cells and of a specific isotype of StuB' in similar 
human cells correlates with the ability of such cells 
to follow an alternative splicing pathway. 
2. MATERIALS AND METHODS 
2.1. Western blotting 
Prior to electrophoresis, the protein content of cell samples 
was equalized by using a modified Lowry assay [13]. Equal 
amounts of protein from each sample were then electrophores- 
ed on 12.5070 polyacrylamide SDS gels, transferred to 
nitrocellulose and reacted with antibody as described [14]. 
Monoclonal antibody KSm5 [12], which detects the StuB and 
B' proteins was used as the first layer and peroxidase con- 
jugated rabbit anti-mouse immunoglobulin asthe second layer. 
The fact that each sample contained an equivalent amount of 
protein was confirmed by scanning the protein bands in an 
unblotted portion of the gel stained with Coomassie Blue stain 
using a Joyce-Loebel chromoscan 3 densitometer. 
2.2. Two-dimensional gel el ctrophoresis 
Samples were electrophoresed on nonequilibrium pH gra- 
dient gels as described by O'Farrell et al. [15]. The gradient gel 
was then transferred to the slot of a 12.5070 polyacrylamide g l 
and after electrophoresis, was treated as described above. 
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3. RESULTS AND DISCUSSION 
The KSm5 antibody used in these experiments 
[12] reacts with the closely related Stub and B' 
proteins. Using this antibody we were able to 
detect only a single band with the mobility of SmB 
in a wide range of rodent cells (fig. la). Although 
there was some variation in the amount of SmB 
present in the different cell lines, it was clearly 
detectable in all the lines studied including both 
suspension and attached cell lines, primary, im- 
mortalised and transformed cells, as well as 
transformed cell lines derived from all three germ 
layers. However, in the pluripotent mouse em- 
bryonal carcinoma (EC) cell line PCC3 [16] StuB' 
was readily detectable, although the level of SmB 
was similar to that observed in most other cell 
types (fig.la). A similar result was also obtained 
with two other murine EC cell lines, PCC4 and F9, 
suggesting that the presence of StuB' is typical of 
mouse EC cell lines. In contrast overloading the 
amount of protein from differentiated cells so that 
the amounts of SmB in these cells exceeded that 
seen in the EC cells failed to reveal any SmB' in 
the differentiated cells. As expected, both the SmB 
and SmB' proteins were located in the nucleus of 
the EC cells and reacted with human SLE sera con- 
taining antibodies to Sm as well as with another 
monoclonal ntibody directed against the SmB and 
B' proteins (KSm4: 12, not shown). 
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Fig. 1. Western blot of protein samples from mouse (a) and 
human (b) cell lines with antibody KSm5. Track 1, PCC3; track 
2, A20 (B lymphocytes); track 3, LS109.2 (pre-B cell); track 4, 
PYS (parietal endoderm); track 5, PSA5E (visceral endoderm); 
track 6, Tera 2; track 7, HeLa. Arrows indicate the position of 
molecular mass markers of the sizes indicated and of the SmB 
and B' proteins. 
To investigate he expression of SmB' in human 
EC cells, we compared the proteins detected by 
KSm5 in HeLa cells with those observed in the 
human EC cell line Tera 2 [17]. As expected from 
previous studies [10,11], HeLa cells contained 
readily detectable l vels of StuB' protein which 
however, was less abundant than StuB. In contrast 
Tera 2 cells contained elevated levels of StuB' 
resulting in a considerable excess of B' compared 
to B protein (fig.lb). Hence, increased levels of 
SmB' are a general characteristic of EC cells 
whatever their species of origin, although the basal 
level of this protein in differentiated cells varies 
dramatically between humans and rodents. 
The expression of StuB' in human and rodent 
cells was further studied by two-dimensional gel 
electrophoresis u ing a non-equilibrium pH gra- 
dient as the first dimension [15], followed by 
polyacrylamide gel electrophoresis and Western 
blotting with KSm5. In differentiated mouse cells 
typified by A20 lymphocytes (fig.2a) no B ' protein 
was detectable, the antibody recognising only a 
single basic spot with the molecular mass of StuB. 
The position of this spot correlated well with that 
observed by others who have used similar techni- 
ques to study the Sm proteins [18]. In PCC3 cells 
StuB' was detectable (fig.2b) as a single spot at the 
same isoelectric point as SmB but at higher 
molecular mass. Hence in mouse cells, these ex- 
periments confirm those using one dimensional 
gels, StuB' being detected only in EC cells. 
In human cells the situation ismore complex. As 
expected, in view of its detection in one- 
dimensional gel electrophoresis, SmB' was ob- 
served in two-dimensional gels of HeLa cell pro- 
teins (fig.2c). The major StuB' spot is, however, 
more basic than the major Stub spot, only a very 
small amount of StuB' material being detectable 
(arrowed in fig.2c) at the same pI as the major 
Stub spot. In Tera 2 cells by contrast, considerably 
more B' material was detectable at this point of 
the gel (arrowed in fig.2d), whilst the abundance of
the more basic StuB' spot was little different from 
that in HeLa cells. Hence, exactly as in mouse EC 
cells, an isotype of StuB' with the same isoelectric 
point as SmB is over-expressed in human EC cells. 
Interestingly, a more basic form of Stub observed 
in HeLa cells (fig.2c) is absent in Tera 2 cells 
(fig.2d). The significance of this observation is at 
present uncertain, however. 
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Fig.2. Two-dimensional Western blots with antibody KSm5. Protein samples were f om A20 lymphocyte c lls (a), PCC3 cells (b), HeLa 
cells (c) and Tera 2 cells (d). Arrows labelled B and B' indicate the position of the Stub and B' proteins in the second dimension gel 
as determined by co-electrophoresis of HeLa cell protein in a single slot of the second dimension gel followed by Western blotting. 
The + and - signs indicate the basic and acidic ends of the first dimension gel, respectively. The arrowed spot is discussed in the text. 
The elevated levels of  SmB'  in human and 
mouse EC cells detected in one-dimensional  gels 
thus appear  to be due at least in part  to elevated ex- 
pression of  a more acidic StuB'  isotype. This oc- 
curs despite the fact that human cells have high 
levels of  a more basic isotype o f  SmB'  which is 
undetectable in rodent cells. 
The presence of  SmB'  in EC cells suggested that 
it might also be detected in mouse embryos.  F ig.3a 
shows that this was indeed the case, SmB'  being 
detectable in the total  protein obtained f rom 13 
day embryos.  However,  the expression of  this pro-  
tein in embryos was found to be tissue specific, the 
prote in being undetectable in the foetal liver, but 
expressed at high level in foetal brain (fig.3a). Fur-  
ther experiments showed that such over-expression 
o f  SmB'  was also observed in adult  brain (where 
SmB'  is detectable at considerable higher levels 
than SmB) compared  to adult  liver (fig.3a). Other 
adult  tissues such as kidney and spleen showed a 
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Fig.3. Western blot of rodent issues (a) nd cell lines (b) with 
antibody KSm5. Track 1, 13-day mouse embryo (strain CBA); 
track 2, 13-day foetal iver; track 3, 13-day foetal brain; track 
4, adult mouse brain; track 5, adult mouse liver; track 6, A20 
lymphocytes; track 7, PCI2 adrenal medullary carcinoma. 
Arrows indicate the position and sizes of molecular mass 
markers. 
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similar pattern to that observed in the liver. This 
suggests that elevated expression of SmB' 
represents a consistent tissue specific difference 
between brain and other organs regardless of the 
stage of development. 
The detection of elevated SmB' levels in cells as 
distinct as EC cells and foetal and adult brain 
raises questions as to the significance of this effect. 
One common feature of such cells is that both EC 
cells and some neurons in the brain express the 
alternatively spliced calcitonln/CGRP gene [19,20] 
and are capable of processing the primary 
transcript to mature CGRP mRNA [19,21].' 
Experiments in which a calcitonin/CGRP gene 
was constitutively expressed in a variety of cell 
types by transfection [19] and the construction of 
transgenic mice [21] suggested that this processing 
ability is found in only a small minority of cell 
types. Thus the vast majority of cells, including all 
the cells we have shown to lack SmB', appear to 
be capable of processing the primary transcript to 
yield only the caicitonln mRNA. These ex- 
periments, together with mutational nalysis of the 
calcitonin/CGRP gene, have led to the suggestion 
[19,21] that whilst the constitutively expressed 
splicing apparatus can readily produce calcitonin 
mRNA from the primary transcript, the produc- 
tion of CGRP mRNA required the presence of an 
additional splicing factor allowing ceils containing 
it to follow an alternative splicing pathway. Our 
data suggest that SmB' may be this splicing factor. 
In agreement with this idea SmB' is detectable in
three rat hyroid medullary carcinoma cell lines 
[22,23] which produce CGRP, further extending 
the correlation of SmB' expression with the ability 
to splice for CGRP mRNA (fig.4). 
If SmB' is indeed required for specific RNA 
splicing, it should also be observed in rodent cell 
types such as the PC12 rat adrenal medullary car- 
cinoma line [24] which is capable of processing the 
primary calcitonin/CGRP transcript o produce 
CGRP mRNA following transfection [19] 
although it does not naturally express the 
calcitonin/CGRP gene. Fig,3b shows that this 
prediction iscorrect. The SmB' protein was clearly 
detectable in these cells but not in the A20 lym- 
phocyte line which has been shown to produce only 
the calcitonin mRNA following transfection [19]. 
Hence expression of SmB' appears to be 
associated with an alternative splicing pathway 
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Fig.4. Western blot of rodent thyroid medullary carcinoma cell 
lines, with antibody KSm5. Track 1, rat MTC 6-23 cells; track 
2, rat MTC 44-2 cells; track 3, rat MTC 6-23 C cell ine. Arrows 
indicate the positions and sizes of molecular mass markers. 
which in EC cells and some neurons allows the pro- 
duction of CGRP mRNA rather than calcitonin 
mRNA. The expression of SmB' in other cells that 
do not normally express the calcitonin/CGRP gene 
presumably reflects other alternative splicing deci- 
sions in these cells for example that which pro- 
duces ubstance P rather than substance K in some 
neurons [4]. The ability to follow this alternative 
splicing pathway may be dependent on the 
presence of the more acidic isotype of SmB', 
which is present in both human and rodent EC 
cells. Alternatively this ability may simply depend 
on the elevation of total StuB' levels above that 
typical of most cells in the species concerned, this 
possibility being suggested by the observation that 
variation in the concentration f splicing extracts 
can affect the choice of splice site in vitro [25]. 
The development of in vitro splicing systems 
which mimic the tissue specific regulation of alter- 
native splicing observed in vivo will be necessary to
distinguish these possibilities. Whatever the precise 
mechanisms, however, our findings indicate that 
cell type specific variation in at least one of the Sm 
components of the spliceosome does occur, and 
that such variation may play an important role in 
the regulation of at least one alternative RNA 
splicing pathway. Similarly, other examples of 
alternative splicing found in cell types lacking 
StuB' (see for example [3]) may be regulated by as 
yet unidentified tissue specific variants of the Sm 
proteins. 
135 
Volume 243, number 2 FEBS LETTERS January 1989 
Acknowledgements: We thank Peter Broad, R.F. Gagel, Cathy 
Lowndes and F.N. Zeytin for the gift o  cell lines. This work 
was supported in part by the Arthritis and Rheumatism Coun- 
cil. N.G.S. is supported by an MRC postgraduate studentship. 
REFERENCES 
[1] Amara, S.G., Jonas, V., Rosenfeld, M.G. Ong, E.S. and 
Evans, R.M. (1982) Nature 298, 240-244. 
[2] Breithart, R.E. and Nadal-Ginard, B. (1987) Cell 49, 
793-803. 
[3] Early, P., Rogers, J., David, M., Calame, K., Bond, M., 
Wall, R. and Hood, L. (1980) Cell 20, 313-319. 
[4] Nawa, H., Kotani, H. and Nakanishi, S. 0984) Nature 
312, 729-734. 
[5] Lerner, M.R. and Steitz, J.A. (1979) Proc. Natl. Acad. 
Sci. USA 76, 5495-5499. 
[6] Padgett, R.A., Mount, S.M., Steitz, J.A. and Sharp, 
P.A. 0983) Cell 35, 101-107. 
[7] Maniatis, T. and Reed, R. (1987) Nature 325, 673-678. 
[8] Padgett, R.A., Grabowski, P.J., Konarska, M.M., Seller, 
S. and Sharp, P.A. (1966) Annu. Rev. Biochera. 55, 
Ill9-1150. 
[9] Hardin, J.A. 0986) Arthritis Rheum. 29, 457-460. 
[10] Guldner, H.H., Lakomek, H.J. and Bautz, F.A. (1983) J.
Immunol. Methods 64, 45-59. 
[l 1] Hintenberg, M., Pettersson, I. and Steitz, J.A. (1983) J. 
Biol. Chem. 258, 2604-2613. 
[12] Williams, D.G., Stocks, M.R., Smith, P.R. and Maini, 
R.N. (1986) Immunology 58, 495-500. 
[13] Cadman, E.J., Bostwick, R. and Eichberg, J. (1979) 
Anal. Biochem. 96, 21-29. 
[14] La Thangue, N.B., Shriver, K., Dawson, C. and han, 
W.L. (1984) EMBO J. 3, 267-277. 
[15] O'Farrell, P.Z., Goodman, H.M. and O'Farrell, P.H. 
(1977) Cell 12, 1133-1142. 
[16] Jakob, H., Boon, T., Galliard, J., Nicholas, J.F. and 
Jacob, F. (1973) Ann. Microbiol. Inst. Pasteur 124b, 
269-282. 
[17] Andrews, P.W., Damjanov, 1., Simon, D., Banting, 
G.S., Carlin, C., Dracopoli, N.C. and Fogh, J. 0984) 
Lab. lnvest. 50, 147-162. 
[18] Elkon, K.B. and Janknowski, P.W. (1985) J. Immunol. 
134, 3819-3824. 
[19] Left, S.E., Evans, R.M. and Rosenfeld, M.G. (1987) Cell 
48, 517-524. 
[20] Evain-Biron, D., Binet, E. Donnadieu, M., Laurent, P. 
and Anderson, W.B. (1984) Dev. Biol. 104, 406-412. 
[21] Crenshaw, E.B., Russo, A.F., Swanson, L.W. and 
Rosenfeld, M.G. (1987) Cell 49, 389-398. 
[22] Zeytinoglu, F.N., Gagel, R.F., De Leliis, R.A., Wolfe, 
H.J., Tashijan, A.H. and Hammer, R.A. (1983) Lab. 
Invest. 49, 453-459. 
[23] Zeytin, F.N., Rusk, S. and Left, S.E. (1987) 
Endocrinology 121, 361-370. 
[24] Greene, L.A. and Tischler, A.S. (1976) Proc. Natl. Acad. 
Sci. USA 73, 2424-2428. 
[25] Reed, R. and Maniatis, T. (1986) Cell 46, 681-690. 
136 
